Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Assets Average (2016 - 2025)

Historic Assets Average for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to $18.4 million.

  • Outlook Therapeutics' Assets Average fell 2206.66% to $18.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.4 million, marking a year-over-year decrease of 2206.66%. This contributed to the annual value of $19.7 million for FY2019, which is 836.61% down from last year.
  • As of Q4 2025, Outlook Therapeutics' Assets Average stood at $18.4 million, which was down 2206.66% from $20.5 million recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Assets Average ranged from a high of $23.6 million in Q4 2024 and a low of $18.0 million during Q1 2025